North America Vaccine Adjuvants Market – Size, Outlook, Trends and Forecast (2024

North America Vaccine Adjuvants Market - Size

Study Period

2018 - 2030

Base Year For Estimation

2023

Forecast Data Period

2024-2030

Historical Data Period

2018-2021

CAGR

7 %

Source: Envision Intelligence Analysis & Experts Insights.

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities.

North America Vaccine Adjuvants Market Segments Size & Growth:

North America vaccine adjuvants market size is projected to reach approximately $278 million by the end of 2024 with a CAGR of close to 11.3% from $168.5 million in 2017 during the forecast timeline 2018-2024. Key parameters promoting the market growth include increasing use of recombinant subunit and synthetic vaccines, Unmet Vaccine market needs for certain diseases, technological innovations and Expanding government recommendations for immunisations. However, lack of scientific awareness of adjuvants, Funding/cost of developing a new adjuvant, strict regulatory factors, high toxicity adjuvants and side effects of adjuvants are thereby hampering the market growth.

North America Vaccine Adjuvants Market Segments Share:

North America vaccine adjuvants market is categorized type which comprises of

North America Vaccine Adjuvants Market - Growth

Source: Envision Intelligence Analysis & Experts Insights.

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

Aluminium Salts, Tensoactive Adjuvants, Adjuvant Emulsions, Bacteria derived Adjuvants, Liposome Adjuvants, Carbohydrate Adjuvants, others. Among them, Adjuvant Emulsions holds the most significant share in the market. By Route of administration into oral, intradermal, and intranasal. Among them, intranasal segment holds the largest share in the market. By the mechanism of action into active immunostimulants, carriers, and vehicle adjuvants. On the basis of Geography, USA is projected to dominate the market with the largest share and the growth in the North America economies is mainly attributed because of huge profit margins and growth prospects.

North America Vaccine Adjuvants Market Trends:

Leading global biotherapeutics company CSL Limited (ASX: CSL), officially opened a new AUD$230 million advanced manufacturing facility at its CSL Behring site in Broadmeadows with the assistance of Victorian Minister for Industry and Employment, Ben Carroll, MP.
Novavax, Inc. announced the Phase 3 trial of its RSV F protein recombinant nanoparticle vaccine (RSV F Vaccine) for infants via maternal immunization will continue.
Agenus Inc., an immuno-oncology company with a pipeline of immune checkpoint antibodies and cancer vaccines, announced a $230 million non-dilutive royalty transaction with HealthCare Royalty Partners (HCR).

North America Vaccine Adjuvants Market Research Report:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.

Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact in altering the market dynamics.

Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

The primary market players, such as

MPV Technologies
Avanti Polar Lipids
Agenus, Inc.
Invivogen
SPI Pharma, Inc.

immunization will continue. Agenus

You can also purchase parts of this report. Do you want to check out a section wise price list

North America Vaccine Adjuvants Market - Porter's Five Force Analysis

Source: Envision Intelligence Analysis & Experts Insights.

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

Credibility and
Transparency

We actively recruit consumers, business professionals, and elusive individuals for our research panels, fostering enduring relationships. Our commitment to transparency is evident in the comprehensive listing of primary and secondary data sources, ensuring unwavering credibility in our reports.

Exhaustive
Coverage

Uncover the full spectrum with Envision Intelligence. Our detailed and extensive geographical coverage, coupled with survey consultation services, spans brand tracking, concept testing, and consumer behaviour analysis. Adapt to your evolving needs with scalable market research services that leave no facet unexplored.

Competitive
Edge

Stay ahead with Envision Intelligence. Our reports provide the latest market updates up to the date of purchase. Recognising the urgency of impactful decisions, we deliver timely analyses on the unprecedented choices made by CXOs during the COVID-19 crisis—providing valuable insights at no extra cost.

Golden
pportunities

Unearth hidden gems with Envision Intelligence. Our analysts and consultants conduct a comprehensive strategic sieve analysis, augmented by AI tools, to identify non-obvious, golden, and emerging opportunities. Evaluate possibilities that set you apart in the market.

Top-notch Reportsd
Guaranteed

Experience unparalleled depth with Envision Intelligence. Over 70% of our research is exclusive, establishing us as the premier source for in-depth and extensive market insights. Elevate your decision-making with reports that go beyond the ordinary.

Post Purchase
Support

Empower your journey with Envision Intelligence. Our commitment extends beyond the purchase. Enjoy post-purchase support for three months, with queries addressed within 24 business hours via telephone or email. We stand by you in your quest for ongoing success.